BRPI1014720A2 - uso de compostos de 1-fenil-3-dimetilaminopropano para o tratamento da dor reumatoide - Google Patents

uso de compostos de 1-fenil-3-dimetilaminopropano para o tratamento da dor reumatoide

Info

Publication number: BRPI1014720A2
Authority: BR; Brazil
Prior art keywords: phenyl; treatment; rheumatoid pain; dimethylaminopropane compounds; dimethylaminopropane
Prior art date: 2009-04-30

Application number

BRPI1014720A

Other languages

English (en)

Inventor

Klaus Schiene

Ulrich Jahnel

Original Assignee

Gruenenthal Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-04-30

Filing date

2010-04-26

Publication date

2016-04-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41050250&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1014720(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-04-26 Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh

2016-04-12 Publication of BRPI1014720A2 publication Critical patent/BRPI1014720A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Dermatology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI1014720A 2009-04-30 2010-04-26 uso de compostos de 1-fenil-3-dimetilaminopropano para o tratamento da dor reumatoide BRPI1014720A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP09005980		2009-04-30
PCT/EP2010/002606 WO2010124856A1 (en)	2009-04-30	2010-04-26	Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain

Publications (1)

Publication Number	Publication Date
BRPI1014720A2 true BRPI1014720A2 (pt)	2016-04-12

Family

ID=41050250

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1014720A BRPI1014720A2 (pt)	2009-04-30	2010-04-26	uso de compostos de 1-fenil-3-dimetilaminopropano para o tratamento da dor reumatoide

Country Status (24)

Country	Link
US (4)	US20100280128A1 (pt)
EP (2)	EP2424514B1 (pt)
JP (1)	JP5993303B2 (pt)
KR (4)	KR20120015332A (pt)
CN (2)	CN102438607A (pt)
AU (1)	AU2010243907C1 (pt)
BR (1)	BRPI1014720A2 (pt)
CA (1)	CA2757757C (pt)
CY (1)	CY1118822T1 (pt)
DK (1)	DK2424514T3 (pt)
ES (1)	ES2625949T3 (pt)
HR (1)	HRP20170551T1 (pt)
HU (1)	HUE032695T2 (pt)
IL (1)	IL215695A (pt)
LT (1)	LT2424514T (pt)
MX (1)	MX2011011442A (pt)
MY (1)	MY174008A (pt)
PH (1)	PH12017500270A1 (pt)
PL (1)	PL2424514T3 (pt)
PT (1)	PT2424514T (pt)
SG (2)	SG10201401455WA (pt)
SI (1)	SI2424514T1 (pt)
WO (1)	WO2010124856A1 (pt)
ZA (1)	ZA201107708B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2694049B1 (en)	2011-04-05	2018-10-31	Grünenthal GmbH	Tapentadol for preventing chronification of pain
SI2701693T1 (sl)	2011-04-29	2017-11-30	Gruenenthal Gmbh	Tapentadol za preprečevanje in zdravljenje depresije in anksioznosti
JP6360488B2 (ja) *	2012-11-01	2018-07-18	トレント・ファーマシューティカルズ・リミテッドＴｏｒｒｅｎｔＰｈａｒｍａｃｅｕｔｉｃａｌｓＬｉｍｉｔｅｄ	非経口投与のためのタペンタドールの薬学的組成物
CN108227067B (zh)	2017-11-13	2021-02-02	南京矽力微电子技术有限公司	一种光学结构以及具有该光学结构的电子设备

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4426245A1 (de) *	1994-07-23	1996-02-22	Gruenenthal Gmbh	1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
AU2003251993A1 (en) *	2002-07-19	2004-02-09	Inge Grundke-Iqbal	NMDA RECEPTOR ANTAGONISTS AND THEIR USE IN INHIBITING ABNORMAL HYPERPHOSPHORYLATION OF MICROTUBULE ASSOCIATED PROTEIN tau
ATE465726T1 (de) *	2002-11-22	2010-05-15	Gruenenthal Gmbh	Verwendung von (1r, 2r)-3-(3-dimenthylamino-1- ethyl-2-methyl-propyl)-phenol zur behandlung von entzündungsschmerz
WO2008134071A1 (en)	2007-04-26	2008-11-06	Theraquest Biosciences, Inc.	Multimodal abuse resistant extended release formulations
DE102007019417A1 (de) *	2007-04-23	2008-11-13	Grünenthal GmbH	Tapentadol zur Schmerzbehandlung bei Arthrose
CN102908339A (zh) *	2007-11-23	2013-02-06	格吕伦塔尔有限公司	他喷他多组合物
SI2352494T1 (sl) *	2008-10-30	2019-12-31	Gruenenthal Gmbh	Nove in potentne dozirne oblike tapentadola

2010
- 2010-04-26 JP JP2012507636A patent/JP5993303B2/ja active Active
- 2010-04-26 EP EP10721109.6A patent/EP2424514B1/en not_active Revoked
- 2010-04-26 MY MYPI2011004997A patent/MY174008A/en unknown
- 2010-04-26 HU HUE10721109A patent/HUE032695T2/en unknown
- 2010-04-26 ES ES10721109.6T patent/ES2625949T3/es active Active
- 2010-04-26 CN CN201080019155XA patent/CN102438607A/zh active Pending
- 2010-04-26 SI SI201031443A patent/SI2424514T1/sl unknown
- 2010-04-26 DK DK10721109.6T patent/DK2424514T3/en active
- 2010-04-26 SG SG10201401455WA patent/SG10201401455WA/en unknown
- 2010-04-26 KR KR1020117028184A patent/KR20120015332A/ko active Search and Examination
- 2010-04-26 PT PT107211096T patent/PT2424514T/pt unknown
- 2010-04-26 SG SG2011074283A patent/SG175184A1/en unknown
- 2010-04-26 WO PCT/EP2010/002606 patent/WO2010124856A1/en active Application Filing
- 2010-04-26 KR KR1020177000121A patent/KR20170005189A/ko not_active Application Discontinuation
- 2010-04-26 CN CN201610050743.9A patent/CN105640927A/zh active Pending
- 2010-04-26 BR BRPI1014720A patent/BRPI1014720A2/pt not_active Application Discontinuation
- 2010-04-26 EP EP16161025.8A patent/EP3069717A1/en not_active Ceased
- 2010-04-26 AU AU2010243907A patent/AU2010243907C1/en active Active
- 2010-04-26 CA CA2757757A patent/CA2757757C/en active Active
- 2010-04-26 MX MX2011011442A patent/MX2011011442A/es active IP Right Grant
- 2010-04-26 LT LTEP10721109.6T patent/LT2424514T/lt unknown
- 2010-04-26 KR KR1020217006070A patent/KR20210027513A/ko not_active Application Discontinuation
- 2010-04-26 PL PL10721109T patent/PL2424514T3/pl unknown
- 2010-04-26 KR KR1020197022872A patent/KR20190095522A/ko not_active IP Right Cessation
- 2010-04-27 US US12/768,232 patent/US20100280128A1/en not_active Abandoned
2011
- 2011-10-11 IL IL215695A patent/IL215695A/en active IP Right Grant
- 2011-10-20 ZA ZA2011/07708A patent/ZA201107708B/en unknown
2016
- 2016-08-09 US US15/232,419 patent/US20160346228A1/en not_active Abandoned
2017
- 2017-02-13 PH PH12017500270A patent/PH12017500270A1/en unknown
- 2017-04-04 HR HRP20170551TT patent/HRP20170551T1/hr unknown
- 2017-04-13 CY CY20171100437T patent/CY1118822T1/el unknown
- 2017-07-31 US US15/664,555 patent/US20170326079A1/en not_active Abandoned
2018
- 2018-04-24 US US15/960,909 patent/US20180235909A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN102438607A (zh)	2012-05-02
HUE032695T2 (en)	2017-10-30
EP3069717A1 (en)	2016-09-21
LT2424514T (lt)	2017-04-25
CA2757757C (en)	2017-10-24
IL215695A (en)	2015-11-30
CA2757757A1 (en)	2010-11-04
EP2424514B1 (en)	2017-02-22
US20170326079A1 (en)	2017-11-16
MX2011011442A (es)	2011-11-18
CY1118822T1 (el)	2018-01-10
WO2010124856A1 (en)	2010-11-04
SI2424514T1 (sl)	2017-05-31
EP2424514A1 (en)	2012-03-07
CN105640927A (zh)	2016-06-08
IL215695A0 (en)	2012-01-31
SG175184A1 (en)	2011-12-29
KR20170005189A (ko)	2017-01-11
JP2012525344A (ja)	2012-10-22
US20180235909A1 (en)	2018-08-23
KR20210027513A (ko)	2021-03-10
AU2010243907A1 (en)	2011-11-03
AU2010243907B2 (en)	2015-04-23
PH12017500270A1 (en)	2017-09-04
MY174008A (en)	2020-03-03
ZA201107708B (en)	2012-07-25
JP5993303B2 (ja)	2016-09-14
PL2424514T3 (pl)	2017-08-31
DK2424514T3 (en)	2017-05-08
SG10201401455WA (en)	2014-07-30
KR20190095522A (ko)	2019-08-14
KR20120015332A (ko)	2012-02-21
US20100280128A1 (en)	2010-11-04
ES2625949T3 (es)	2017-07-21
PT2424514T (pt)	2017-05-30
HRP20170551T1 (hr)	2017-06-02
US20160346228A1 (en)	2016-12-01
AU2010243907C1 (en)	2015-09-03

Publication	Publication Date	Title
BRPI1012116A2 (pt)	2016-03-15	composição farmacêutica para o tratamento de doenças cardíacas
BR112013014943A2 (pt)	2016-09-13	compostos úteis para o tratamento de aids
BRPI1015569A2 (pt)	2016-08-16	compostos úteis para o tratamento de doenças degenerativas e inflamatórias.
BRPI0908428A2 (pt)	2015-12-08	uso de ranozalina para tratar a dor.
BRPI1013698A2 (pt)	2016-04-26	métodos para tratamento com o uso de terapia de combinação
BR112012013260A2 (pt)	2016-03-15	dispositivo usado para o tratamento de rinite através de iluminação bioestimulativa
BRPI0908026A2 (pt)	2015-07-21	Métodos para o tratamento de doenças do intestino
BR112013011874A2 (pt)	2019-09-24	compostos e métodos para tratar dor
BR112012031836A2 (pt)	2016-11-08	combinação farmacêutica para o tratamento da dor
UY33094A (es)	2011-07-29	Procedimiento para la preparacion de dronedarona
BR112012000502A2 (pt)	2017-05-16	terapia de combinação para o tratamento de diabetes
BR112014013843A2 (pt)	2017-07-04	uso de dispositivos para o tratamento de doenças neurológicas
BR112012004836A2 (pt)	2019-09-24	pirazinilpiridinas úteis para o tratamento de doenças proliferativas
BR112012001797A2 (pt)	2017-05-16	composto bicíclico e uso do mesmo para propósitos médicos
BRPI0912687A2 (pt)	2016-01-26	uso de bactéria probiótica para o tratamento de hiperhomocisteinaemia
BRPI0816712A2 (pt)	2016-11-08	terapia de intervalo para o tratamento de tinnitus
BRPI1014528A2 (pt)	2016-04-05	compostos para tratamento de inflamação e dor
BRPI1007995A2 (pt)	2019-09-24	orto-aminoamidas para o tratamento de cãncer.
BRPI0918050A2 (pt)	2015-09-22	compostos de tetraciclina para o tratamento de artrite reumatoide e metodos relacionados de tratamento
BRPI1009448A2 (pt)	2016-03-01	combinações farmacêuticas compreendendo edea119/bay 869766 para o tratamento de cânceres específicos
BRPI0922367A2 (pt)	2016-05-24	enzastaurin para o tratamento de câncer
BRPI0912890A2 (pt)	2015-10-20	composição farmacêutica para o tratamento de ejaculação precoce
BRPI0915927A2 (pt)	2016-06-07	uso de inibiodores de hdac para o tratamento da doença de hodgkin
BRPI0814409A2 (pt)	2014-10-14	Tratamento de dor neuropática
BRPI1014720A2 (pt)	2016-04-12	uso de compostos de 1-fenil-3-dimetilaminopropano para o tratamento da dor reumatoide

Legal Events

Date	Code	Title	Description
2017-10-24	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-10	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-04-16	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-04-30	B06T	Formal requirements before examination [chapter 6.20 patent gazette]
2020-06-02	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2020-09-15	B09B	Patent application refused [chapter 9.2 patent gazette]
2020-11-24	B12B	Appeal against refusal [chapter 12.2 patent gazette]